Lymphoma, a type of blood cancer, occurs when white blood cells begin behaving abnormally, and do not properly protect the body from infections and diseases. There are two main types of lymphoma, Hodgkin Lymphoma and Non-Hodgkin Lymphoma, and although between 30 and 60 percent of patients with lymphoma can be cured through different treatment methods like chemotherapy and radiation therapy, there are still problems with lymphoma being resistant to some drugs used. The National Cancer Institute, part of the NIH, recently awarded the University of Arizona Tucson a 5-year, $1.59 million life science grant to study methods of combating drug resistance in lymphoma treatments.
Read More
1 Comment Click here to read/write comments
Tags: 2014, University of Arizona, Southwest, AZ, UAZ, BioResearch Product Faire Event, Tucson
Tuberculosis (TB) affects people all over the world, although over 95 percent of the cases are in developing countries. TB is caused by a bacteria called Mycobacterium tuberculosis (Mtb) that affects the lungs, which can stay in the body for many months before any symptoms are seen, leading to the transmission of the disease between people. Unlike many other universal diseases, though, tuberculosis is curable if caught in time and preventable. Even with known cures for TB, scientists are still studying the structure of the Mtb protein to find ways of using it to design future drugs.
Read More
0 Comments Click here to read/write comments
Tags: Texas A&M University, Southwest, 2015, College Station, TAMU, BioResearch Product Faire Event, TX
The National Institute of Health recently awarded the University of Texas Austin School of Nursing a $2.4 million grant to establish a new research center that will largely focus on treating individual, family, and community chronic health conditions. As one of two institutions in the U.S. to receive this award, UT Austin will be a national model to future research centers of this type.
Read More
0 Comments Click here to read/write comments
Tags: University of Texas, Southwest, UTAust, 2015, Austin, BioResearch Product Faire Event, TX
The Department of Defense has awarded the University of Texas Austin, along with 11 other U.S. institutions, a 5 year award of $17 million to develop successful treatments for these injuries.
Read More
1 Comment Click here to read/write comments
Tags: University of Texas, Southwest, UTAust, 2015, Austin, BioResearch Product Faire Event, TX
Are you a laboratory supplier who is looking to expand your presence in the Southern California area and increase your influence at the top California Universities?
0 Comments Click here to read/write comments
Tags: 2014, CA, University of Southern California, Southwest, USC, Los Angeles, LAVS, BioResearch Product Faire Event, Irvine, UCI, UC Irvine, Biotechnology Vendor Showcase Event
It’s not an uncommon dream for cancer researchers and patients afflicted with cancer to find a way to make cancer cells self-destruct: Remarkably, cancer researchers at the University of Texas, Austin may have found a way to do just that. By ferrying sodium and chloride ions into the cancer cells, the cells are triggered to go through apoptosis, or a programmed cell death.
0 Comments Click here to read/write comments
Tags: 2014, University of Texas, cancer research, Southwest, UTAust, Austin, BioResearch Product Faire Event, 1 day only, TX, cancer researchers
The National Institutes of Health has awarded the University of California, Los Angeles a $7.2 million life science grant to study genetic diseases and develop ways to diagnose rare genetic disorders. UCLA is the only university on the West Coast and one of only three in the United States with a laboratory that can carry out genomic sequence directly usable for patient care, making it the ideal university to receive this life science grant.
0 Comments Click here to read/write comments
Tags: 2014, CA, new research funding, Southwest, Los Angeles, LAVS, UCLA, Biotechnology Vendor Showcase, life science grant, UC Los Angeles
Researchers at the University of Southern California recently received $10.3 million in life science funding to help support the Southern California Clinical and Translational Science Institute. The project leader is Dr. Thomas Buchanan of the University of Southern California’s Keck School of Medicine, and the funding organization within the National Institutes of Health is the National Center for Advancing Translational Sciences. The new science research funding will help researchers and doctors improve medical treatment for patients in urban areas.
0 Comments Click here to read/write comments
Tags: 2014, CA, University of Southern California, new research funding, Southwest, USC, Los Angeles, BioResearch Product Faire Event, new research grant
The University of California, Irvine recently hosted a gala that raised $1.6 million in science research funding for the Chao Family Comprehensive Cancer Center, a part of UC Irvine Health. More than 500 people were in attendance at the event, which was held at Disney’s Grand California Hotel and Spa.
0 Comments Click here to read/write comments
Tags: 2014, CA, Southwest, BioResearch Product Faire Event, Irvine, UCI, UC Irvine, life science research grants, life science research funding
The University of California, San Diego recently received a $12.5 million grant from the National Institutes of Health to fund Alzheimer’s disease research. The 2014 study was awarded life science research funding from the administering institute: National Institute on Aging. Dr. Paul Aisen, the project leader, joined the Department of Neurosciences at UCSD in 2007. Before being appointed director of the Alzheimer’s Disease Cooperative Study (ADCS) at the University of California, San Diego, he was a professor of neurology and medicine and director of the Memory Disorders Program at Georgetown University School of Medicine.
0 Comments Click here to read/write comments
Tags: 2014, CA, new research funding, Southwest, San Diego, SDVS, UCSD, 1 day only, UC San Diego, Biotechnology Vendor Showcase, new grant, new funding